Immunome Reports Second Quarter 2023 Financial Results

By WebmasterAugust 9, 2023November 1st, 2024No Comments

Immunome Reports Second Quarter 2023 Financial Results

Previous PostVenatorx Pharmaceuticals Highlights Two Recent Publications Indicating Rising Metallo-Beta-Lactamases for Carbapenem-Resistant Enterobacterales in US
Next PostRelmada Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results